Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deborah M Levy

Showing results (81-90 of 101) with videos related to

Pageof 11
Sort By:
The Journal of Rheumatology|February 2, 2022
Best Practices for Virtual Care: A Consensus Statement From the Canadian Rheumatology AssociationClaire E H Barber, Deborah M Levy, Vandana Ahluwalia, et al.
Annals of the Rheumatic Diseases|January 10, 2023
Towards development of treat to target (T2T) in childhood-onset systemic lupus erythematosus: PReS-endorsed overarching principles and points-to-consider from an international task forceEve Mary Dorothy Smith, Amita Aggarwal, Jenny Ainsworth, et al.
The Journal of Rheumatology|October 15, 2022
Canadian Rheumatology Association Recommendations for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis-Associated UveitisRoberta Berard, Hon Yan Ng, Andrea Human, et al.
Pediatric Nephrology (Berlin, Germany)|October 17, 2022
Acute kidney injury requiring kidney replacement therapy in childhood lupus nephritis: a cohort study of the Pediatric Nephrology Research Consortium and Childhood Arthritis and Rheumatology Research AllianceBrian R Stotter, Ellen Cody, Hongjie Gu, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 19, 2018
Establishing Surrogate Kidney End Points for Lupus Nephritis Clinical Trials: Development and Validation of a Novel Approach to Predict Future Kidney OutcomesMeggan Mackay, Maria Dall'Era, Joanna Fishbein, et al.
The Journal of Rheumatology|August 5, 2025
Intravenous Golimumab in Children With Polyarticular-Course Juvenile Idiopathic Arthritis: Long-Term Extension of an Open-Label Phase III StudyHermine I Brunner, César Pacheco-Tena, Ingrid Louw, et al.
Arthritis and Rheumatism|May 1, 2009
Premature atherosclerosis in pediatric systemic lupus erythematosus: risk factors for increased carotid intima-media thickness in the atherosclerosis prevention in pediatric lupus erythematosus cohortLaura E Schanberg, Christy Sandborg, Huiman X Barnhart, et al.
The Journal of Rheumatology|August 1, 2024
Intravenous Golimumab in Children With Polyarticular-Course Juvenile Idiopathic Arthritis: Long-Term Extension of an Open-Label Phase III StudyHermine I Brunner, César Pacheco-Tena, Ingrid Louw, et al.
Arthritis Care & Research|March 21, 2017
Health-Related Quality of Life in an Inception Cohort of Children With Juvenile Idiopathic Arthritis: A Longitudinal AnalysisKiem Oen, Jaime Guzman, Brenden Dufault, et al.
The Journal of Allergy and Clinical Immunology|November 15, 2021
TNF inhibition in vasculitis management in adenosine deaminase 2 deficiency (DADA2)Natalie T Deuitch, Dan Yang, Pui Y Lee, et al.
Pageof 11

Showing results (81-90 of 101) with videos related to

Sort By:
Pageof 11
The Journal of Rheumatology|February 2, 2022
Best Practices for Virtual Care: A Consensus Statement From the Canadian Rheumatology AssociationClaire E H Barber, Deborah M Levy, Vandana Ahluwalia, et al.
Annals of the Rheumatic Diseases|January 10, 2023
Towards development of treat to target (T2T) in childhood-onset systemic lupus erythematosus: PReS-endorsed overarching principles and points-to-consider from an international task forceEve Mary Dorothy Smith, Amita Aggarwal, Jenny Ainsworth, et al.
The Journal of Rheumatology|October 15, 2022
Canadian Rheumatology Association Recommendations for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis-Associated UveitisRoberta Berard, Hon Yan Ng, Andrea Human, et al.
Pediatric Nephrology (Berlin, Germany)|October 17, 2022
Acute kidney injury requiring kidney replacement therapy in childhood lupus nephritis: a cohort study of the Pediatric Nephrology Research Consortium and Childhood Arthritis and Rheumatology Research AllianceBrian R Stotter, Ellen Cody, Hongjie Gu, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 19, 2018
Establishing Surrogate Kidney End Points for Lupus Nephritis Clinical Trials: Development and Validation of a Novel Approach to Predict Future Kidney OutcomesMeggan Mackay, Maria Dall'Era, Joanna Fishbein, et al.
The Journal of Rheumatology|August 5, 2025
Intravenous Golimumab in Children With Polyarticular-Course Juvenile Idiopathic Arthritis: Long-Term Extension of an Open-Label Phase III StudyHermine I Brunner, César Pacheco-Tena, Ingrid Louw, et al.
Arthritis and Rheumatism|May 1, 2009
Premature atherosclerosis in pediatric systemic lupus erythematosus: risk factors for increased carotid intima-media thickness in the atherosclerosis prevention in pediatric lupus erythematosus cohortLaura E Schanberg, Christy Sandborg, Huiman X Barnhart, et al.
The Journal of Rheumatology|August 1, 2024
Intravenous Golimumab in Children With Polyarticular-Course Juvenile Idiopathic Arthritis: Long-Term Extension of an Open-Label Phase III StudyHermine I Brunner, César Pacheco-Tena, Ingrid Louw, et al.
Arthritis Care & Research|March 21, 2017
Health-Related Quality of Life in an Inception Cohort of Children With Juvenile Idiopathic Arthritis: A Longitudinal AnalysisKiem Oen, Jaime Guzman, Brenden Dufault, et al.
The Journal of Allergy and Clinical Immunology|November 15, 2021
TNF inhibition in vasculitis management in adenosine deaminase 2 deficiency (DADA2)Natalie T Deuitch, Dan Yang, Pui Y Lee, et al.
Pageof 11